300642.SZ
Tellgen Corp.
SZSE · Healthcare · C 制造业 · CN
CNY 13.50
−1.53%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 16.51
From 52W high−52.09%
Volume21.57M
Market capCNY 2.19B
P/E (TTM)610.6x
P/S (TTM)7.4x
Div yield0.88%
Key dataSep 18, 2026
Open
CNY 16.51
From 52W high
−52.09%
Volume
21.57M
Market cap
CNY 2.19B
ValuationView details →
P/E (Fwd)
13.9x
EV/EBITDA
48.1x
P/E (TTM)
610.6x
RSI (14)
54.0
MomentumView details →
1D Return
−1.53%
YTD Return
−7.78%
Similar companies
Latest newsMore news →
Shanghai Tellgen Life Science's controlling subsidiaries Jiangxi Tellgen and Maishi Biology obtained two medical device registration certificates from the Jiangxi and Shanghai drug regulators for an automated flow fluorescence immunoassay analyzer and a four-item antiepileptic drug concentration assay kit.2d agoShanghai Rongzhen Investment Group, a specific shareholder of Tellgen Corporation, announced plans to reduce its stake by up to 0.77% of total shares via centralized bidding between September 9 and December 8, 2026.17d agoTellgen Corporation and its subsidiary Mise Bio submitted six medical device registration applications that were accepted by the Shanghai Municipal Drug Administration for review.40d ago